ABSTRACT
INTRODUCTION
Oral controlled release dosage forms have been developed over the past three decades due to their considerable therapeutic advantages such as ease of administration, patient compliance and flexibility in formulation. Microsphere carrier systems made from the naturally occurring biodegradable polymers have attracted considerable attention for several years in sustained drug delivery. Recently, dosage forms that can precisely control the release rates and target drugs to a specific body site have made an enormous impact in the formulation and development of novel drug delivery systems [1] [2] [3] . They have varied applications and are prepared using assorted polymers 4 . However, the success of these microspheres is limited owing to their short residence time at the site of absorption. It would, therefore, be advantageous to have means for providing an intimate contact of the drug delivery system with the absorbing membranes [5] [6] [7] [8] . This can be achieved by coupling bioadhesion characteristics to microspheres and developing bioadhesive microspheres. Bioadhesive microspheres have advantages such as efficient absorption and enhanced bioavailability of drugs owing to a high surface-tovolume ratio, a much more intimate contact with the mucus layer, and specific targeting of drugs to the absorption site [9] [10] [11] [12] . Gelatin (obtained by boiling skin, tendons and ligaments with water) is a cationic polymer that has been proposed for use in microsphere systems by a number of authors [13] [14] [15] [16] [17] . Gelatin was selected as a polymer in the preparation of mucoadhesive microspheres because of its good mucoadhesive and biodegradable properties. Hence, there is a need to develop an oral drug delivery system that is, convenient for patients. Various synthetic and natural polymers like alginate, gelatin and chitosan have been used to develop drug delivery systems for entrapping and delivery drugs orally 20 IR spectroscopy was performed on Fourier transformer infrared spectrometer (Nicolet, India). The pellets of drug and potassium bromide (1:1) were prepared by compressing at 20 psi for 10 min on KBr-press and the spectra were scanned in the wave number range of 4000-600 cm -1 for the sample of Deflazacort, Gelatin and Physical mixture of drug and polymer. Particle size analysis 21 The samples of the optimized formulation (F4), were analyzed for their particle size distribution by using Malvern Particle Size Analyzer. Percentage yield 21 The Percentage yield of prepared microspheres was de termined by using the formula.
MATERIALS AND METHODS

Deflazacort
Evaluation of Microspheres Drug Polymer interaction (FTIR) Study
Percentage yield = Practical yield
Theoritica lyield
× 100
Determination of drug content 100 mg of microspheres of F1, F2, F3, F4 and F5was weighed and dissolved in 10ml of ethanol. The solution was suitably diluted with phosphate buffer pH 7.4 in 100ml standard flask and filtered to separate the fragments, and drug content was analysed by UV spectrophotometer (SHIMADZU, Japan) at a wavelength of 247 nm. 21 The entrapment efficiency was calculated from the ratio of actual to theoretical drug content and expressed as percentage. The formula applied is Flow properties of microspheres were investigated by determining by following standard procedures.
Determination of entrapment efficiency
Bulk Density
Bulk density was determined by taking a known weight of dried microspheres in a measuring cylinder and tapping 3 times from 1 inch height at 2 sec. interval. The Bulk volume is noted and the Bulk density was calculated from the following equation.
Bulk density =
Weight of microspheres Bulk volume of microspheres Tapped Density Tapped density is the ratio of mass of microsphere to the volume occupied by the same mass of the powder after a standard tapping of a measure. Weighed quantity of microspheres was taken in a cylinder and tapping 300 times from 1 inch at 2 sec intervals. The tapped volume is noted and the tapped density was calculated from the equation 
Compressibility Index
Compressibility index was determined by using bulk density and tapped density.
Compressibilty index = Tapped density−Bulk density
Tapped density
×100
Angle of Repose A funnel was fixed to a stand and bottom of the funnel was fixed at a height of 3 cm from the plane. Microspheres were placed in funnel and allowed to flow freely and the height and radius of the heap of microspheres was measured. θ= tan -1 h/r Where, 'h' is the height of heap and 'r' is the radius of heap of microspheres.
In vitro drug release 25 In vitro drug release study was carried out in USP XXIII basket type dissolution test apparatus using phosphate buffer pH7.4 as dissolution medium, Volume of dissolution medium was 900 ml and bath temperature was maintained at (37±1) ° C throughout study. Stirring speed was adjusted to 100 rpm 26 . At predetermined time intervals, an aliquot of 5ml was withdrawn and replenished with fresh medium. Amount of drug in each aliquot was determined using a UV-Spectrophotometer at 247nm.
RESULTS AND DISCUSSION
In the present work sustained release microspheres of deflazacort were formulated using gelatin polymer and glutaraldehyde as a cross-linking agent. The sustained release microspheres of Deflazacort prepared by cross-linking were found to be almost spherical and free flowing. The particle size analysis by Malvern sizer reveals that the average mean diameter of F4 formulation was found to be 1178 (1.18 µ) nm (Fig 2) . It was observed that as the polymer ratio in the formulation increase, the product yield also increases. The low Percentage yielding some formulation may be due to microspheres lost during the washing process. The Percentage drug content in the formulation was found to be 32.94% to 66.50%. Entrapment efficiency of microspheres was found to be 42.56 % to 86.50%. The Percentage Drug Entrapment efficiency of all batches varied. The idea of Percentage of loading and dosage calculation is obtained from the Percentage drug entrapment efficiency data. As the drug entrapment efficiency is nearer to 100% for any batch it shows best drug loading and required less amount of formulation dosage to be administered, compared to the less percentage drug entrapment batch. Here Deflazacort release from the microsphere was studied for 12 h the drug released at constant rate in all the preparation and showed sustained release. The results of F4 formulation prepared with 1:4 concentration of drug: gelatin showed a release of maximum 84.94% at pH 7.4 in 12 h, similar pattern was observed in the case of other formulations. Data obtained from in vitro release studies was utilized for release kinetics. The in vitro release of F4 was fit into various kinetic models to find out the mechanism of drug release. Among this highest correlation coefficient was shown in higuchi release kinetics (r 2 =0.893) followed by first order (r 2 =0.824). The slope of the koresmeyer peppas plot (n=0.6305) was found to be more than 5 indicating the diffusion was anomalous diffusion (non fickian diffusion). 
CONCLUSION
The present study demonstrated the successful formulation of Deflazacort microsphere using gelatin as natural biodegradable polymer and release the drug in a sustained manner for an extended period of time. This can help to maximize the therapeutic effect of the drug, reduce side effect, decrease the dose and frequency of dosing and also helps to improve patient compliance. 
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